1)柿崎 弘,阿部優子,菅野 理,他:尿路性器癌を含む多重癌100症例の検討.日泌尿会誌 83:1841-1846,1992
2)Kawakami S, Fukui I, Yonase J, et al:Multiple primary malignant neoplasms associated with prostate cancer in 312 consecutive cases. Urol Int 59:243-247, 1997
3)橿淵啓史,梶原隆広,板倉宏尚,他:前立腺癌患者における多重癌の臨床的検討.泌尿器外科 12:45-48,1999
4)河嶋厚成,高橋 徹,岡 聖次,他:前立腺生検時に発見された膀胱腫瘍の検討.西日泌尿 68:480-482,2006
5)山田大介,井上高明,陶山文三:前立腺癌検診を契機に発見された膀胱腫瘍についての検討.臨泌 58:687-689,2004
6)Matsuda T, Marugame T and The Japan Cancer Surveillance Research Group:Cancer incidence and incidence rates in Japan in 2002:based on data from 11 population-based cancer registries. Jpn J Clin Oncol 38:641-648, 2008
7)Chun TY:Coincidence of bladder and prostate cancer. J Urol 157:65-67, 1997
8)Mahadevia PS, Koss LG, Tar IJ, et al:Prostatic involvement in bladder cancer:prostate mapping in 20 cystoprostatectomy specimens. Cancer 58:2096-2102, 1986
9)Kakizoe T, Matsumoto K, Nishio Y, et al:Double cancer observed from bladder cancer. Jpn J Clin Urol 37:805-809, 1983
10)Kurokawa K, Suzuki K, Okazaki H, et al:Usefullness of PSA screening in outpatients with bladder cancer:preliminary results. Int J Urol 9:237-240, 2002
11)Fradet Y:Molecular and immunologic approaches in the management of the bladder cancer. Urol Clin North Am 18:515, 1991
12)Moul JW, Gaddipati J and Srivastava S:Molecular biology of prostate cancer:oncogenes and tumor suppressor genes. In:Prostate Cancer. edited by Dawson NA and Vogelzang JJ. Wiley-Liss, New York, pp19-46, 1994
13)Amara N, Palapattu GS, Schrage M, et al:Prostate stem cell antigen is overexpressed on human transitional cell carcinoma. Cancer Res 61:4660-4665, 2001
14)McDonald DF and Lund RR:Role of urine in vesical neoplasms, experimental confirmation of urogeneous theory of pathogenesis(using β-naphtylamine as carcinogenic agent). J Urol 71:560-570, 1954
15)Hess MJ, Zhan EH, Foo DK, et al:Bladder cancer in patients with spinal cord injury. J Spinal Cord Med 26:335-338, 2003